Doxorubicin is a type of anthracycline chemotherapy drug used to treat certain types of solid tumors and blood cancers. It has a number of side effects, some more serious than others. Experts ...

Doxorubicin HCl 10mg/vial, 20mg/vial, 50mg/vial; pwd for IV inj after reconstitution; contains lactose. Risk of cardiomyopathy (including left ventricular failure), arrhythmias. Pre-existing heart ...

A phase 2 study showed that giving maintenance regorafenib could delay disease progression in patients with non-adipocytic ...

In view of the patient's long progression-free survival (12.9 months), we decided to resume intramuscular octreotide (30 mg every 3 weeks) with capecitabine and liposomal doxorubicin chemotherapy ...

The first site in Race Oncology’s Phase 1 clinical trial of RC220 in advanced solid tumours has been activated with the first ...

In the Phase Two expansion stage, patients with solid tumours will be enrolled, receiving the optimal dosage of RC220 in combination with doxorubicin to check the safety of these two combined ...

Polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) reduces the risk for disease progression, relapse, or death by 37% vs standard therapy in patients ...

Discover all the brand names or Trade names of generic drug called Doxorubicin. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the CD30-directed antibody-drug conjugate (ADC ...

AstraZeneca and Daiichi Sankyo’s Enhertu followed by THP showed an improved safety profile vs. standard of careFirst Phase III trial to demonstrate benefit of Enhertu in early breast cancer Positive ...